Christopher Blanchette

Author

University of North Carolina at Charlotte

Also Known As

Christopher B. Blanchette, Christopher Blanchette

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Charlotte Lovelace Respiratory Research Institute Lovelace Clinic Foundation Research Otsuka (United States)

About

Christopher Blanchette is an author at University of North Carolina at Charlotte specializing in epidemiology, engineering, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	897
2	Health Sciences	2	2	35
3	Medicine	2	2	35
4	Epidemiology	2	2	897
5	Public Health	1	1	133

Christopher Blanchette

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals Stanley Xu, Colleen Ross, Marsha A. Raebel, Value in Health EngineeringConfidence IntervalsEstimation StatisticRisk ManagementTreatment Effect	2009	764
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group Sandra Nestler-Parr, D Korchagina, Mondher Toumi, Value in Health Disease DiagnosisEpidemiologyEngineeringDigital HealthDiagnosis	2018	133
Comorbidities and length of stay in chronic obstructive pulmonary disease patients Lanny Inabnit, Christopher Blanchette, Cynthiya Ruban COPD Journal of Chronic Obstructive Pulmonary Disease	2018	29
End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases Steven M. Brunelli, Christopher Blanchette, Ami Claxton, ClinicoEconomics and Outcomes Research	2015	26
Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management Melissa Roberts, Douglas W. Mapel, Hans Petersen, Journal of Medical Economics	2011	26
Evaluating cost benefits of combination therapies for advanced melanoma I. Jensen, Emily Zacherle, Christopher Blanchette, Drugs in Context	2016	23
Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function Christopher Blanchette, Anthony P. Nunes, Nancy U. Lin, Drugs in Context	2015	22
Outpatient Costs of Medications for Patients with Chronic Heart Failure Leslie C. Hussey, Sonya R. Hardin, Christopher Blanchette American Journal of Critical Care	2002	22
Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease Anand A. Dalal, Douglas W. Mapel, Melissa Roberts, International Journal of COPD	2010	18
Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality Elisabet Viayna, Eric A. Gehrie, Christopher Blanchette, Blood Advances Health SciencesHealth EconomicsLonger HospitalizationsBlood TransfusionHematology	2022	18

Page 1